Moderna
Search results
5 days ago · AstraZeneca has upgraded a 2020 alliance with Fusion Pharma focusing on radioconjugate therapies for cancer, opting to buy the firm outright in a deal worth around $2 billion.
2 days ago · As wepreviously reported, Alexion Pharmaceuticals, Inc. and Alexion Pharma International Operations Ltd. (collectively, "Alexion") sued Samsung Bioepis Co. Ltd. ("Samsung") in January 2024 in the U.S. District Court for the District of Delaware, alleging infringement of six patents under the BPCIA based on Samsung's submission of its BLA for SB12, a proposed biosimilar to SOLIRIS (eculizumab).
4 days ago · ALXN-5500: a C5 inhibitors Drug, Initially developed by Alexion Pharmaceuticals, Inc., Now, its global highest R&D status is Phase 1, Mechanism: C5 inhibitors(Complement C5 inhibitors), Therapeutic Areas: Hemic and Lymphatic Diseases,Other Diseases, Active Indication: Hemoglobinuria, Paroxysmal, Active Org.: Alexion Pharmaceuticals ...
5 days ago · BioMarin is a global biotechnology company that has developed medicines to treat conditions such as achondroplasia, severe hemophilia A, and several rare inherited and lysosomal storage diseases. Learn more.
3 days ago · Bristol-Myers Squibb Co. has announced it will acquire Amylin Pharmaceuticals for approximately US $5.3 billion in cash. Following the completion of this acquisition...
1 day ago · Adrian Kielhorn, Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc. Story continues. Health Economics and Market Access. Economic impact evaluations using real-world evidence.
5 days ago · Associate Research Scientist III. Location: New Haven, United States Job reference: R-203653 Date posted: 06/28/2024. As a part of our growing Translational Research team, Alexion pharmaceuticals is seeking a highly motivated research scientist with diverse laboratory skills to join our collaborative team focused on developing innovative ...
